• Publications
  • Influence
A placebo-controlled, randomized clinical trial comparing sertraline and imipramine for the treatment of dysthymia.
BACKGROUND Despite the high prevalence of dysthymia and its associated morbidity, few controlled trials have evaluated the efficacy of antidepressant medication for this disorder. A 12-week,Expand
  • 188
  • 12
Quantitative cytoarchitectural studies of the cerebral cortex of schizophrenics.
Quantitative morphometric determinations of neuronal and glial density, neuron-glia ratios, and neuronal size were performed in the prefrontal, anterior cingulate, and primary motor cortex of tenExpand
  • 491
  • 9
Use of phenelzine in continuation therapy.
In 18 depressed patients, phenelzine had proved to be a beneficial drug during treatment of the acute illness. Following 4 weeks' remission induced by either 45 or 60 mg/day, patients were assignedExpand
  • 25
  • 2
Long-term safety and clinical acceptability of venlafaxine and imipramine in outpatients with major depression.
The antidepressant efficacy and safety of venlafaxine was shown previously in 6-week, placebo-controlled trials. We evaluated the long-term safety and clinical acceptability of venlafaxine andExpand
  • 89
  • 1
Diagnostic significance of vegetative symptoms in depression.
The diagnostic importance of vegetative symptoms for melancholia was examined through DSM-III, the Newcastle Scale, and Extracted Criteria for melancholia. Statistically significant differences wereExpand
  • 51
  • 1
A typology of parasuicide.
Parasuicide is not a single syndrome. Subtypes at present recognized are based largely on clinically derived stereotypes. When considering a series of patients, the clinician is unable to handle moreExpand
  • 36
  • 1
Positron emission tomography of the thyroid, with an emphasis on thyroid cancer
The role of Positron Emission Tomography (PET) using 18F-fluorodeoxyglucose (FDG) in the management of thyroid cancer is discussed. It is important to ensure that patients are relaxed because uptakeExpand
  • 65
The first clinical study of BW-234U in schizophrenia.
  • 32
Early and late side effects of phenelzine.
  • 25
An outpatient evaluation of phenelzine and imipramine.
Phenelzine and imipramine were evaluated in a 5-week double-blind study of outpatients with major depression. Median daily doses of phenelzine 75 mg and imipramine 150 mg were employed. Of 27Expand
  • 22